10-QHealthcare

Pfizer Inc

PFE · Period ending 2026-09-27 · Filed 2026-11-03 · Updated

In short

Pfizer Inc (PFE) has revenue down 1.6% to $62.6B and net income down 3.2% to $7.8B year on year. Its net margin is 12.4%, and it trades at 44.7× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this

Compare: JNJ vs PFE · ABBV vs PFE · MRK vs PFE · LLY vs PFE

Valuation

Healthcare
Live · Yahoo Finance

Price

$27.40

Market Cap

$156.2B

P/E (TTM)

39.1x

Price ÷ earnings per share

P/B

1.8x

Price ÷ book value

P/S (TTM)

2.5x

Price ÷ revenue per share

Beta

0.30

Low volatility vs market

PEG Ratio

8.4x

P/E ÷ earnings growth rate

52-Week Range

$23.62$27.40 now$31.44

Decision Context

Market appears to be pricing in less growth than this company's historical average, suggesting potential upside if the trajectory continues. Quality and efficiency scores support the business case.

Based on filing period ending Sept 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

PFE vs

Macro Context

Fed Funds Rate

3.88%

Accommodative

10-Year Treasury

5.13%

2026-10-01

Unemployment

4.2%

Near full employment

CPI Index

336.3

2026-09-01

M2 Money Supply

$23.4T

2026-09-01

The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.

SWOT Analysis — PFE

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

No standout strengths identified from the filing.

◈

Weaknesses

  • Operating Cash Flow: $11.7B (-8.2% YoY) — Operating cash flow fell 8% but remained positive.

  • EPS (Diluted): $1.36 (-3.5% YoY) — Earnings per share fell 4%.

  • Net Income: $7.8B (-3.2% YoY) — Profit fell 3% but remained positive.

  • Total Assets: $208.2B (-2.5% YoY) — Total assets shrank 2% — the balance sheet contracted.

  • Revenue: $62.6B (-1.6% YoY) — Revenue fell 2% — the company generated less from its core operations.

  • Stock is near its 52-week high (31.33) — the price reflects strong recent momentum, but entry risk is elevated at these levels.

◎

Opportunities

No clear opportunities identified at this time.

⚠

Threats

  • Current ratio of 1.16x — thin liquidity buffer against short-term obligations.

Year-over-Year Changes

Operating Cash Flow

$11.7B

was $12.7B

−8.2%

Operating cash flow fell 8% but remained positive.

EPS (Diluted)

$1.36

was $1.41

−3.5%

Earnings per share fell 4%.

Net Income

$7.8B

was $8.0B

−3.2%

Profit fell 3% but remained positive.

Total Assets

$208.2B

was $213.4B

−2.5%

Total assets shrank 2% — the balance sheet contracted.

Revenue

$62.6B

was $63.6B

−1.6%

Revenue fell 2% — the company generated less from its core operations.

Risk Flags

0 high · 1 medium · 1 low
  • ◈ Medium

    Current ratio of 1.16x — thin liquidity buffer against short-term obligations.

  • ○ Low

    Stock is near its 52-week high (31.33) — the price reflects strong recent momentum, but entry risk is elevated at these levels.

Technical Signals

Daily closes · 1-year data

Pfizer Inc: common questions

Is Pfizer Inc profitable?

Yes. Pfizer Inc made a net profit of $7.8B in its latest fiscal year (fiscal 2025), a net margin of 12.4%.

Is Pfizer Inc's revenue growing?

No. Revenue fell 1.6% year on year, to $62.6B.

What is Pfizer Inc's P/E ratio?

Pfizer Inc trades at 39.1× its trailing twelve-month earnings. In other words, the share price is about 39 times the profit per share the company earned over the past year.

Does Pfizer Inc pay a dividend?

Yes. Pfizer Inc's forward dividend yield is 6.28%, the expected annual dividend as a share of the current share price.

What are the main risks for Pfizer Inc?

Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Current ratio of 1.16x — thin liquidity buffer against short-term obligations.

Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — PFE

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade PFE

Links open broker research pages. Not an endorsement or recommendation.

Research Pfizer Inc

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.